Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

α-N-acetylgalactosaminidase in Acute Exacerbation and Remission Stages of Schizoaffective Disorder

NCT07673718 is registered in ClinicalTrials.gov with Elazığ Mental Health and Diseases Hospital as lead sponsor.

NCT NCT07673718
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07673718 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
α-N-acetylgalactosaminidase in Acute Exacerbation and Remission Stages of Schizoaffective Disorder
Lead sponsor
Elazığ Mental Health and Diseases Hospital
Phase
Observational
Overall status
Completed
Start date
April 25, 2025
Completion date
July 30, 2025
Enrollment
93 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder